Last Price$35.33.2%
Market Cap$3,219.3M
Last Earnings date
Jun'24
Q2 2024
$0.00
100.0% beat
$160.2M
11.3% beat
Next quarter EPS Estimate
($0.56)
229.4%YoY
LEGN Earnings and Expectations
Revenue
Crunching data... Almost there!
LEGN EPS (Earnings Per Share)
Crunching data... Almost there!
LEGN Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
LEGN Earnings History
| Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $10.1M | $10.1M | $17.7M | $19.5M | $11.5M | $11.6M | $11.7M | $40.8M | $13.7M | $20.2M | $16.9M | $39.0M | $40.8M | $12.0M | $27.4M | $27.6M | $36.3M | $73.3M | $96.0M | $79.5M | $94.0M | $186.5M | $160.2M |
| Revenue estimate | N/A | N/A | N/A | N/A | N/A | $13.0M | $13.0M | $13.0M | $6,500.0K | $9,133.3K | $7,833.3K | $14.3M | $25.0M | $33.6M | $32.3M | $32.3M | $42.2M | $56.6M | $97.3M | $94.1M | $143.2M | $125.3M | $143.9M |
| Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.8% | 9.6% | 213.7% | 110.5% | 121.5% | 115.5% | 173.3% | 63.3% | 64.4% | 15.4% | 14.6% | 13.8% | 29.5% | 1.3% | 15.5% | 34.4% | 48.9% | 11.3% |
| EPS actual | ($0.12) | ($0.29) | ($0.28) | ($0.64) | ($0.34) | ($1.25) | ($0.50) | ($0.44) | ($0.61) | ($0.66) | ($0.87) | ($0.60) | ($0.27) | ($1.25) | ($0.27) | ($0.85) | ($0.68) | ($1.14) | ($0.34) | ($0.80) | ($0.33) | ($0.10) | $0.00 |
| EPS estimate | N/A | N/A | N/A | N/A | N/A | ($0.26) | ($0.31) | ($0.28) | ($0.35) | ($0.34) | ($0.42) | ($0.34) | ($0.36) | ($0.31) | ($0.37) | ($0.37) | ($0.42) | ($0.36) | ($0.31) | ($0.36) | ($0.19) | ($0.29) | ($0.33) |
| EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 380.8% | 63.0% | 55.3% | 74.3% | 97.0% | 109.3% | 75.5% | 24.7% | 303.0% | 27.7% | 127.7% | 62.9% | 215.9% | 9.6% | 125.0% | 70.6% | 65.3% | 100.0% |
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
Crunching data... Almost there!
Competing with LEGN Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$3,219.3M | $520.2M | ($1.23) | 66.9% | (100.0%) | Beat by 27.9% | Miss by 100.0% | 11.7% | 0.0% | Beats: 9 Misses: 1 | 117.0% | (70.8%) | |
$388.2B | DKK 290.4B | DKK 22.67 | 30.1% | 28.9% | Beat by 7.9% | Beat by 5.9% | (6.5%) | 0.4% | Beats: 5 Misses: 5 | 20.0% | 23.2% | |
$125.7B | $11.0B | ($2.06) | 15.7% | (5.6%) | Beat by 4.5% | Miss by 11.1% | (3.9%) | 23.5% | Beats: 8 Misses: 2 | 6.8% | (988.1%) | |
$76.1B | $14.2B | $40.88 | 10.3% | (21.6%) | Beat by 0.8% | Miss by 23.9% | (7.6%) | 23.6% | Beats: 7 Misses: 3 | 3.4% | 9.5% | |
$35.7B | $2,258.9M | ($1.77) | 73.8% | N/A | Beat by 40.1% | Miss by 281.3% | 23.0% | 0.7% | Beats: 8 Misses: 2 | 76.9% | (142.5%) | |
$31.4B | $2,248.2M | ($2.17) | 34.9% | (40.9%) | Beat by 1.6% | Beat by 27.8% | (7.3%) | 14.3% | Beats: 7 Misses: 3 | 16.9% | (55.3%) | |
$26.1B | €3,040.1M | (€1.96) | 39.0% | 20.3% | Beat by 761.0% | Miss by 141.1% | (10.3%) | (51.6%) | Beats: 5 Misses: 5 | (28.2%) | (182.9%) | |
$14.1B | $2,877.4M | $26.45 | 19.7% | 45.9% | Miss by 0.5% | Beat by 2.4% | 3.0% | 6.7% | Beats: 5 Misses: 5 | 10.7% | 9.9% | |
$13.7B | $3,229.0M | ($9.29) | (65.7%) | N/A | Miss by 0.7% | Beat by 6.8% | (81.0%) | (0.1%) | Beats: 9 Misses: 1 | (16.2%) | (3.3%) | |
$12.8B | $0.0 | ($0.31) | (100.0%) | 62.6% | undefinedN/A | undefinedN/A | 0.0% | (24.5%) | Beats: Misses: | N/A | 6.8% |
FAQ
1. When was Legend Biotech Corporation's last earnings date?
Legend Biotech Corporation's last earnings date was Jun'24 (Q2 2024).
2. What is Legend Biotech Corporation's EPS, and was there a surprise?
Legend Biotech Corporation's EPS was $0.00, with a 100.0% beat.
3. What is Legend Biotech Corporation's revenue, and was there a surprise?
Legend Biotech Corporation's revenue was $160.2M, with a 11.3% beat.
4. What is Legend Biotech Corporation's next quarter EPS estimate?
Legend Biotech Corporation's next quarter EPS estimate is ($0.56), with an expected 229.4% YoY growth.